Prediction: This Will Be the Next Supercycle After AI Memory. 1 Stock to Buy Now Before It Surges Another 100%.

Lumentum is being positioned as a strategic AI infrastructure supplier, highlighted by Nvidia's $2 billion private placement and multibillion-dollar purchase commitment for advanced laser components. The company’s new 240,000-square-foot Greensboro, North Carolina facility is set to produce InP-based optical devices, but production is not expected to ramp until mid-2028. Despite a 1,110% share surge over the past year, the article argues Lumentum's largest growth drivers may still be ahead as optical interconnect demand accelerates.

Analysis

This is less a single-stock story than a signal that the optical bottleneck is moving from theoretical to budgeted infrastructure. If Nvidia is willing to fund capacity two years ahead of revenue, the implication is that the value capture in the AI stack is shifting from compute silicon alone to the “picks and shovels” that unblock deployment density and power efficiency. That usually marks the start of a multi-year capex wave where the first derivative is supply scarcity, not end-demand growth.

The second-order winner set extends beyond LITE and NVDA. Any vendor with exposure to co-packaged optics, indium phosphide, testing/packaging, photonic integration, or high-speed interconnect should see qualification leverage and pricing power, while copper-centric networking and weaker optical peers risk becoming design-cycle laggards. A domestic fab also creates a political-risk hedge: supply chain localization becomes a procurement feature, which can matter more than cost if customers are prioritizing resilience over absolute margin.

The main risk is timing mismatch. The market is likely discounting a 2028 capacity ramp as if it were nearer-term earnings power, and that gap can create a long stretch where the stock trades on narrative rather than cash flow. If AI capex pauses, if Nvidia’s roadmap shifts toward efficiency gains that reduce transceiver intensity, or if conversion dilution becomes visible before revenue inflects, the multiple can compress hard even while the strategic story remains intact.

Consensus may still be underestimating how early this is in the optical cycle. The crowd is treating photonics as a winner, but not yet as a scarce asset with long-dated supply reservation economics; that distinction matters because reserved capacity tends to produce outsized supplier margins once utilization inflects. The move in LITE looks extended on headline returns, but the setup still has convexity if the market starts marking 2028 capacity as high-confidence earnings rather than optionality.

Key Decisions for Investors

• Maintain/accumulate a tactical long LITE on 3-6 month pullbacks, but size for volatility; risk/reward improves if the market starts pricing the 2028 ramp as a binding supply constraint rather than a distant story.
• Add NVDA exposure versus network-equipment laggards as a paired expression of AI capex intensity: long NVDA / short a basket of copper-heavy or slower-photonics adopters over 6-12 months.
• Buy upside convexity in LITE via call spreads dated 12-18 months out; this captures rerating risk while limiting downside if the ramp slips or conversion dilution caps near-term upside.
• Avoid chasing QRVO on this headline: the asset sale is a signal of industrial reshuffling, not a direct beneficiary, and the cleaner trade is to own the designated strategic supplier rather than adjacent legacy RF exposure.
• Set a risk trigger on any NVDA capex commentary: if hyperscaler spending or transceiver adoption language softens, trim LITE immediately; the stock is likely to de-rate faster than the fundamental deterioration shows up in reported numbers.